NRIX
Nurix Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$26.80
−1.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 11.15x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 34.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- 10.68x
- PEG TTM
- —
- Price / book
- 3.02x
- Price / sales
- 4.17x
- Price / cash flow
- 7.72x
Enterprise value
- Enterprise value
- $1.9B
- EV / sales
- 2.77x
- EV / EBITDA
- 6.03x
- EV / EBIT
- 6.71x
- Market cap
- $2.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Aug 1, 2026